GENERAL COMMENTS
1. The findings were not elaborated differently by crosssectional or longitudinal studies. Whether it's causal relationship or predictive relationship, it would be important to note so the findings might form intervention studies or future research.
2.
The way the findings with regards to determinants of poorer global health status or overall well-being was written is not easy to read. It might be better to develop sub-categories by types of determinants further such as treatment type/completion, psychosocial variables. Or maybe consider to use a model to better frame findings together. 3.
Breast cancer women at early stage vs late stage might have very different experience, is there any difference that can be elaborated in the results? 4.
To present the results, it might be easier to comprehend with a table that checks what determinants were found associated with outcomes. 5.
It seems that findings are very similar to those in the western countries. What's the take home message here? 6.
Given the limitations of the studies based on the quality assessment results, what's the validity of reviewing and summarizing these studies? What's the suggestion for future highquality studies in this area of research?
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GENERAL COMMENTS
The determinants of HRQOL in Asain breast cancer patients should be showed in the conclusion part.
VERSION 1 -AUTHOR RESPONSE
Editorial request:
We agree that using the PICOS format would make our inclusion criteria clearer. We considered the following: Patient -Women diagnosed with breast cancer living in Eastern Asia, South-Central Asia, or SouthEast Asia. Intervention/Exposure -Determinants of poorer health-related quality of life.
Outcome -measured quality of life using EORTC-QLQ-C30 (with or without EORTC-QLQ-BR23), or FACT-G or FACT-B questionnaires Study -Cross-sectional studies or observational longitudinal studies We replaced the sentences: 'All studies published in English that (1) reported results on adult women diagnosed with breast cancer, (2) measured quality of life using EORTC-QLQ-C30 (with or without EORTC-QLQ-BR23), or FACT-G or FACT-B questionnaires, and (3) looked at population living in Eastern Asia, South-Central Asia, or South-East Asia [26] [27] [28] , were eligible for inclusion. Studies published before 2000, systematic reviews, meta-analyses, pilot studies, and studies with qualitative analyses were not included in the current review.' With: 'We included studies which satisfy the following criteria -(1) the study population was on women diagnosed with breast cancer living in Eastern Asia, South-Central Asia, or South-East Asia, (2) the study was on demographics, clinical, treatments or other determinants of health-related quality of life, (3) the study measured quality of life using EORTC-QLQ-C30 (with or without EORTC-QLQ-BR23), or FACT-G or FACT-B questionnaires, (4) the outcome was health-related quality of life measured quality of life using EORTC-QLQ-C30 (with or without EORTC-QLQ-BR23), or FACT-G or FACT-B questionnaires, (5) the study design was either cross-sectional or observational longitudinal studies. Studies published before 2000, in language other than English, systematic reviews, meta-analyses, pilot studies, and studies with qualitative analyses were not included in the current review.' We also suggest splitting the methods section up into sub-headings e.g. search strategy, inclusion criteria, data extraction, quality assessment.
Reviewer 1: We thank Dr Murgic for the kind response.
Reviewer 2: We thank Dr Wen for the insights in this topic. We have attached our response as a separate file.
Reviewer 3:
We agree with Prof Glangkarn that the determinants of HRQOL should be showed in the conclusion and have added the following statement to the conclusion (page 15, line 16 of track change version): 'A shorter time since diagnosis of breast cancer [31, 33, 35, 38-40, 42, 46, 47] , having a Chinese or Indian ethnic background as compared to Malay ethnicity [21, 40, 44] , a lower educational level [21, 35, 41, 48] , and advanced breast cancer stage [38, 40, 42, 49, 50] were associated with poorer HRQL. There is some evidence that patients with co-morbidities or with chemotherapy are more likely to experience poorer HRQL.'
